TipRanks
Rapport Therapeutics, Inc. (RAPP)
NASDAQ:RAPP
US Market
RAPP
Rapport Therapeutics, Inc.
RESEARCH TOOLSreports
Want to see RAPP full AI Analyst Report?

Rapport Therapeutics, Inc. (RAPP) Stock News & Sentiment

156 Followers
RAPP: Buy Initiation Backed by RAP-219 Clinical Progress and Mechanistic Differentiation
Premium
Ratings
RAPP: Buy Initiation Backed by RAP-219 Clinical Progress and Mechanistic Differentiation
14d ago
RAPP
Goldman Sachs Reiterates Buy on RAP-219 Developer, Keeps $62 Price Target on Compelling Bipolar Mania Opportunity
Premium
Ratings
Goldman Sachs Reiterates Buy on RAP-219 Developer, Keeps $62 Price Target on Compelling Bipolar Mania Opportunity
15d ago
RAPP
Douglas Tsao Boosts Rapport Therapeutics Price Target to $66 on Strong RAP-219 Differentiation and Robust Phase 2 Data
Premium
Ratings
Douglas Tsao Boosts Rapport Therapeutics Price Target to $66 on Strong RAP-219 Differentiation and Robust Phase 2 Data
2M ago
RAPP
Rapport Therapeutics: Advancing Phase 3 Epilepsy Pipeline and De-Risked Development Path Underpins Buy Rating
Premium
Ratings
Rapport Therapeutics: Advancing Phase 3 Epilepsy Pipeline and De-Risked Development Path Underpins Buy Rating
2M ago
RAPP
Myles Minter Initiates Buy on Rapport Therapeutics, Citing De-Risked RAP-219 Epilepsy Program and Multi-Billion-Dollar Peak Sales Potential
Premium
Ratings
Myles Minter Initiates Buy on Rapport Therapeutics, Citing De-Risked RAP-219 Epilepsy Program and Multi-Billion-Dollar Peak Sales Potential
2M ago
RAPP
RAP-219’s Differentiated Mechanism Supports Unchanged $65 Price Target and Reiterated Buy on Rapport Therapeutics
Premium
Ratings
RAP-219’s Differentiated Mechanism Supports Unchanged $65 Price Target and Reiterated Buy on Rapport Therapeutics
3M ago
RAPP
Rapport Therapeutics Holds 2026 Annual Shareholder Meeting
Premium
Company Announcements
Rapport Therapeutics Holds 2026 Annual Shareholder Meeting
4M ago
8K
RAPP
More RAPP News >

RAPP News on the Web

BTIG Keeps Their Buy Rating on Rapport Therapeutics, Inc. (RAPP)
TipRanks News
Bullish
Rapport Therapeutics (RAPP) COO Cheryl Gault Sells 10,000 Shares
GuruFocus News
Neutral
RAPP: Buy Initiation Backed by RAP-219 Clinical Progress and Mechanistic Differentiation
TipRanks News
Bullish
Rapport Therapeutics, Inc. at TD Cowen Novel Mechanisms in Neuropsychiatry Conference (Virtual) ...
GuruFocus News
Neutral
Rapport drops after CEO presents at TD Cowen Neuropsychiatry Summit
TipRanks News
Neutral
Rapport Therapeutics, Inc. to Host KOL Event Transcript
GuruFocus News
Neutral
Analysts Conflicted on These NA Names: Rapport Therapeutics, Inc. (RAPP), Idexx Laboratories (IDXX) and Waystar Holding Corp. (WAY)
TipRanks News
Bullish
Analysts Offer Insights on NA Companies: Jack Henry & Associates (JKHY) and Rapport Therapeutics, Inc. (RAPP)
TipRanks News
Bullish

News Score - Last 7 Days

Very Positive
RAPP
Sector Average
Media Buzz
This Week4 articles
Weekly Average4.75 articles
News Sentiment
This Week100%
Sector Average89%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is RAPP’s Media Buzz Sentiment?
4 articles about RAPP were published this week. In an average week, 4.75 articles are published.
    What is RAPP’s weekly average amount of articles?
    In an average week, 4.75 articles about RAPP are published.
      What is RAPP’s News Sentiment?
      100% of articles about RAPP were positive this week, compared to its sector average of 89%.
        General Stocks that are Trending in the News
        RPDRapid7
        TERATera Yatirim Menkul Degerler AS
        R2PD34Rapid7 Inc Shs Unsponsored Brazilian Depositary Receipt Repr 0.083333 Sh
        T2TD34Trade Desk, Inc. Shs A Unsponsored Brazilian Depositary Receipt Repr 0.01 Sh A
        T1AM34Atlassian Corp Shs A Unsponsored Brazilian Depository Receipt Repr 0.05 Sh A
        Showing the stocks with the most bullish news sentiment over the past week